{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:09:52Z","timestamp":1793736592033,"version":"4.6.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00125-021-05637-7","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T02:02:56Z","timestamp":1641520976000},"page":"411-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Metabolic, structural and biochemical changes in diabetes and the development of heart failure"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-3821","authenticated-orcid":false,"given":"Kim L.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qutuba G.","family":"Karwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Pherwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra B.","family":"Ketema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Ussher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Lopaschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"Suppl 2","key":"5637_CR1","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1007\/pl00002934","volume":"44","author":"NJ Morrish","year":"2001","unstructured":"Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S14\u2013S21. https:\/\/doi.org\/10.1007\/pl00002934","journal-title":"Diabetologia"},{"issue":"1","key":"5637_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12933-021-01257-y","volume":"20","author":"S Chen","year":"2021","unstructured":"Chen S, Shen Y, Liu YH et al (2021) Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 20(1):64. https:\/\/doi.org\/10.1186\/s12933-021-01257-y","journal-title":"Cardiovasc Diabetol"},{"issue":"15","key":"5637_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franzen S et al (2017) Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 376(15):1407\u20131418. https:\/\/doi.org\/10.1056\/NEJMoa1608664","journal-title":"N Engl J Med"},{"issue":"5","key":"5637_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.amjcard.2011.10.018","volume":"109","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Maeng M, Thayssen P et al (2012) Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 109(5):629\u2013635. https:\/\/doi.org\/10.1016\/j.amjcard.2011.10.018","journal-title":"Am J Cardiol"},{"issue":"7","key":"5637_CR5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00259-012-2117-9","volume":"39","author":"C Marciano","year":"2012","unstructured":"Marciano C, Galderisi M, Gargiulo P et al (2012) Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease. Eur J Nucl Med Mol Imaging 39(7):1199\u20131206. https:\/\/doi.org\/10.1007\/s00259-012-2117-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5637_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/jcp.46.1.32","volume":"46","author":"M Shimizu","year":"1993","unstructured":"Shimizu M, Umeda K, Sugihara N et al (1993) Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46(1):32\u201336","journal-title":"J Clin Pathol"},{"issue":"3","key":"5637_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/hc0302.102143","volume":"105","author":"E Chou","year":"2002","unstructured":"Chou E, Suzuma I, Way KJ et al (2002) Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105(3):373\u2013379. https:\/\/doi.org\/10.1161\/hc0302.102143","journal-title":"Circulation"},{"issue":"12","key":"5637_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018998","volume":"10","author":"AD Kaze","year":"2021","unstructured":"Kaze AD, Santhanam P, Erqou S, Ahima RS, Bertoni A, Echouffo-Tcheugui JB (2021) Microvascular disease and incident heart failure among individuals with type 2 diabetes mellitus. J Am Heart Assoc 10(12):e018998. https:\/\/doi.org\/10.1161\/JAHA.120.018998","journal-title":"J Am Heart Assoc"},{"issue":"6865","key":"5637_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813\u2013820. https:\/\/doi.org\/10.1038\/414813a","journal-title":"Nature"},{"issue":"3","key":"5637_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2337\/diaspect.21.3.160","volume":"21","author":"BB Dokken","year":"2008","unstructured":"Dokken BB (2008) The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectrum 21(3):160. https:\/\/doi.org\/10.2337\/diaspect.21.3.160","journal-title":"Diabetes Spectrum"},{"issue":"5, Supplement","key":"5637_CR11","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","volume":"53","author":"G Orasanu","year":"2009","unstructured":"Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53(5, Supplement):S35\u2013S42. https:\/\/doi.org\/10.1016\/j.jacc.2008.09.055","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"5637_CR12","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jacc.2006.07.033","volume":"48","author":"M Galderisi","year":"2006","unstructured":"Galderisi M (2006) Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48(8):1548\u20131551","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5637_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2337\/diacare.17.7.633","volume":"17","author":"DC Raev","year":"1994","unstructured":"Raev DC (1994) Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy?: an echocardiographic study of young type I diabetic patients. Diabetes Care 17(7):633\u2013639","journal-title":"Diabetes Care"},{"issue":"3","key":"5637_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0168-8227(88)80016-0","volume":"4","author":"J Attali","year":"1988","unstructured":"Attali J, Sachs R, Valensi P et al (1988) Asymptomatic diabetic cardiomyopathy: a noninvasive study. Diabetes Res Clin Pract 4(3):183\u2013190","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"5637_CR15","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0735-1097(01)01230-X","volume":"37","author":"JE Liu","year":"2001","unstructured":"Liu JE, Palmieri V, Roman MJ et al (2001) The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37(7):1943\u20131949","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5637_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12872-019-1119-y","volume":"19","author":"J Huang","year":"2019","unstructured":"Huang J, Hu HL, Yan ZN et al (2019) Peak systolic longitudinal rotation: a new tool for detecting left ventricular systolic function in patients with type 2 diabetes mellitus by two-dimensional speckle tracking echocardiography. BMC Cardiovasc Disord 19(1):137. https:\/\/doi.org\/10.1186\/s12872-019-1119-y","journal-title":"BMC Cardiovasc Disord"},{"issue":"19","key":"5637_CR17","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/01.cir.101.19.2271","volume":"101","author":"RB Devereux","year":"2000","unstructured":"Devereux RB, Roman MJ, Paranicas M et al (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101(19):2271\u20132276. https:\/\/doi.org\/10.1161\/01.cir.101.19.2271","journal-title":"Circulation"},{"key":"5637_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1749-6632.2002.tb03018.x","volume":"958","author":"SK Rajan","year":"2002","unstructured":"Rajan SK, Gokhale SM (2002) Cardiovascular function in patients with insulin-dependent diabetes mellitus: a study using noninvasive methods. Ann N Y Acad Sci 958:425\u2013430. https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb03018.x","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"5637_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1152\/physrev.1965.45.2.171","volume":"45","author":"RJ Bing","year":"1965","unstructured":"Bing RJ (1965) Cardiac Metabolism. Physiol Rev 45(2):171\u2013213. https:\/\/doi.org\/10.1152\/physrev.1965.45.2.171","journal-title":"Physiol Rev"},{"issue":"1","key":"5637_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0005-2760(89)90328-7","volume":"1006","author":"SR Wall","year":"1989","unstructured":"Wall SR, Lopaschuk GD (1989) Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochim Biophys Acta 1006(1):97\u2013103. https:\/\/doi.org\/10.1016\/0005-2760(89)90328-7","journal-title":"Biochim Biophys Acta"},{"key":"5637_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0002-9343(59)90341-9","volume":"27","author":"WT Goodale","year":"1959","unstructured":"Goodale WT, Olson RE, Hackel DB (1959) The effects of fasting and diabetes mellitus on myocardial metabolism in man. Am J Med 27:212\u2013220. https:\/\/doi.org\/10.1016\/0002-9343(59)90341-9","journal-title":"Am J Med"},{"issue":"10","key":"5637_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1139\/y94-157","volume":"72","author":"M Saddik","year":"1994","unstructured":"Saddik M, Lopaschuk GD (1994) Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 72(10):1110\u20131119. https:\/\/doi.org\/10.1139\/y94-157","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"5637_CR23","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1172\/JCI118173","volume":"96","author":"DE Greenwalt","year":"1995","unstructured":"Greenwalt DE, Scheck SH, Rhinehart-Jones T (1995) Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 96(3):1382\u20131388. https:\/\/doi.org\/10.1172\/JCI118173","journal-title":"J Clin Invest"},{"issue":"34","key":"5637_CR24","doi-asserted-by":"publisher","first-page":"25836","DOI":"10.1016\/S0021-9258(19)74465-2","volume":"268","author":"M Saddik","year":"1993","unstructured":"Saddik M, Gamble J, Witters LA, Lopaschuk GD (1993)Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268(34):25836\u201325845","journal-title":"J Biol Chem"},{"issue":"2","key":"5637_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00019501-199602000-00004","volume":"7","author":"GD Lopaschuk","year":"1996","unstructured":"Lopaschuk GD (1996) Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate\/lipid metabolism. Coron Artery Dis 7(2):116\u2013123. https:\/\/doi.org\/10.1097\/00019501-199602000-00004","journal-title":"Coron Artery Dis"},{"issue":"2","key":"5637_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0925-4439(94)90078-7","volume":"1225","author":"J Gamble","year":"1994","unstructured":"Gamble J, Lopaschuk GD (1994) Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta 1225(2):191\u2013199. https:\/\/doi.org\/10.1016\/0925-4439(94)90078-7","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"5637_CR27","doi-asserted-by":"publisher","first-page":"H2122","DOI":"10.1152\/ajpheart.1998.275.6.H2122","volume":"275","author":"JR Dyck","year":"1998","unstructured":"Dyck JR, Barr AJ, Barr RL, Kolattukudy PE, Lopaschuk GD (1998) Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Phys 275(6):H2122\u2013H2129. https:\/\/doi.org\/10.1152\/ajpheart.1998.275.6.H2122","journal-title":"Am J Phys"},{"issue":"10","key":"5637_CR28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2337\/db07-0481","volume":"56","author":"S Boudina","year":"2007","unstructured":"Boudina S, Sena S, Theobald H et al (2007) Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56(10):2457\u20132466. https:\/\/doi.org\/10.2337\/db07-0481","journal-title":"Diabetes"},{"issue":"12","key":"5637_CR29","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1210\/en.2005-0938","volume":"146","author":"J Buchanan","year":"2005","unstructured":"Buchanan J, Mazumder PK, Hu P et al (2005) Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146(12):5341\u20135349. https:\/\/doi.org\/10.1210\/en.2005-0938","journal-title":"Endocrinology"},{"issue":"3","key":"5637_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","volume":"1801","author":"AR Wende","year":"2010","unstructured":"Wende AR, Abel ED (2010) Lipotoxicity in the heart. Biochimica et Biophysica Acta (BBA)- Molecular and Cell Biology of Lipids 1801(3):311\u2013319. https:\/\/doi.org\/10.1016\/j.bbalip.2009.09.023","journal-title":"Biochimica et Biophysica Acta (BBA)- Molecular and Cell Biology of Lipids"},{"issue":"10","key":"5637_CR31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","volume":"1861","author":"I Zlobine","year":"2016","unstructured":"Zlobine I, Gopal K, Ussher JR (2016) Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochim Biophys Acta 1861(10):1555\u20131568. https:\/\/doi.org\/10.1016\/j.bbalip.2016.02.011","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"5637_CR32","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1172\/JCI40096","volume":"120","author":"I Shimizu","year":"2010","unstructured":"Shimizu I, Minamino T, Toko H et al (2010) Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J Clin Invest 120(5):1506\u20131514. https:\/\/doi.org\/10.1172\/JCI40096","journal-title":"J Clin Invest"},{"issue":"7285","key":"5637_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"281","author":"PJ Randle","year":"1963","unstructured":"Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281(7285):785\u2013789. https:\/\/doi.org\/10.1016\/S0140-6736(63)91500-9","journal-title":"Lancet"},{"issue":"Pt 3","key":"5637_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1042\/bj2820765","volume":"282","author":"M Camps","year":"1992","unstructured":"Camps M, Castello A, Munoz P et al (1992) Effect of diabetes and fasting on GLUT-4 (muscle\/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem J 282(Pt 3):765\u2013772. https:\/\/doi.org\/10.1042\/bj2820765","journal-title":"Biochem J"},{"issue":"2","key":"5637_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0003-9861(71)90244-x","volume":"143","author":"O Wieland","year":"1971","unstructured":"Wieland O, Siess E, Schulze-Wethmar FH, von Funcke HG, Winton B (1971) Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys 143(2):593\u2013601. https:\/\/doi.org\/10.1016\/0003-9861(71)90244-x","journal-title":"Arch Biochem Biophys"},{"issue":"Suppl 2","key":"5637_CR36","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1007\/BF00400839","volume":"37","author":"PJ Randle","year":"1994","unstructured":"Randle PJ, Priestman DA, Mistry S, Halsall A (1994) Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 37(Suppl 2):S155\u2013S161. https:\/\/doi.org\/10.1007\/BF00400839","journal-title":"Diabetologia"},{"issue":"1","key":"5637_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cjca.2020.02.098","volume":"37","author":"M Almutairi","year":"2021","unstructured":"Almutairi M, Gopal K, Greenwell AA et al (2021) The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy. Can J Cardiol 37(1):140\u2013150. https:\/\/doi.org\/10.1016\/j.cjca.2020.02.098","journal-title":"Can J Cardiol"},{"issue":"1","key":"5637_CR38","doi-asserted-by":"publisher","first-page":"108935","DOI":"10.1016\/j.celrep.2021.108935","volume":"35","author":"K Gopal","year":"2021","unstructured":"Gopal K, Al Batran R, Altamimi TR et al (2021) FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity. Cell Rep 35(1):108935. https:\/\/doi.org\/10.1016\/j.celrep.2021.108935","journal-title":"Cell Rep"},{"issue":"7752","key":"5637_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D et al (2019) Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568(7752):351\u2013356. https:\/\/doi.org\/10.1038\/s41586-019-1100-z","journal-title":"Nature"},{"issue":"2","key":"5637_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","volume":"128","author":"Y Deng","year":"2021","unstructured":"Deng Y, Xie M, Li Q et al (2021) Targeting Mitochondria-Inflammation Circuit by \u03b2-Hydroxybutyrate Mitigates HFpEF. Circ Res 128(2):232\u2013245. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317933","journal-title":"Circ Res"},{"issue":"10","key":"5637_CR41","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1161\/01.CIR.0000027569.76671.A8","volume":"106","author":"A Ceriello","year":"2002","unstructured":"Ceriello A, Taboga C, Tonutti L et al (2002) Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation. Circulation 106(10):1211\u20131218. https:\/\/doi.org\/10.1161\/01.CIR.0000027569.76671.A8","journal-title":"Circulation"},{"issue":"6","key":"5637_CR42","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.7150\/thno.40735","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Wu Y, Zhao J et al (2020) Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus. Theranostics 10(6):2675\u20132695. https:\/\/doi.org\/10.7150\/thno.40735","journal-title":"Theranostics"},{"issue":"2","key":"5637_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/01.RES.65.2.378","volume":"65","author":"GD Lopaschuk","year":"1989","unstructured":"Lopaschuk GD, Spafford M (1989) Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 65(2):378\u2013387. https:\/\/doi.org\/10.1161\/01.RES.65.2.378","journal-title":"Circ Res"},{"issue":"5","key":"5637_CR44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/01.res.62.5.931","volume":"62","author":"M Tani","year":"1988","unstructured":"Tani M, Neely JR (1988) Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism. Circ Res 62(5):931\u2013940. https:\/\/doi.org\/10.1161\/01.res.62.5.931","journal-title":"Circ Res"},{"issue":"6","key":"5637_CR45","doi-asserted-by":"publisher","first-page":"E1046","DOI":"10.1152\/ajpendo.2006.263.6.E1046","volume":"263","author":"GD Lopaschuk","year":"1992","unstructured":"Lopaschuk GD, Saddik M, Barr R, Huang L, Barker CC, Muzyka RA (1992) Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats. Am J Phys 263(6):E1046\u2013E1053. https:\/\/doi.org\/10.1152\/ajpendo.2006.263.6.E1046","journal-title":"Am J Phys"},{"issue":"3","key":"5637_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0008-6363(96)88594-4","volume":"29","author":"TL Broderick","year":"1995","unstructured":"Broderick TL, Quinney HA, Lopaschuk GD (1995)L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart. Cardiovasc Res 29(3):373\u2013378","journal-title":"Cardiovasc Res"},{"issue":"9","key":"5637_CR47","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/00004872-200109000-00021","volume":"19","author":"S Carugo","year":"2001","unstructured":"Carugo S, Giannattasio C, Calchera I et al (2001) Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J Hypertens 19(9):1675\u20131680. https:\/\/doi.org\/10.1097\/00004872-200109000-00021","journal-title":"J Hypertens"},{"issue":"10","key":"5637_CR48","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-005-1896-y","volume":"48","author":"A Dawson","year":"2005","unstructured":"Dawson A, Morris AD, Struthers AD (2005) The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 48(10):1971\u20131979. https:\/\/doi.org\/10.1007\/s00125-005-1896-y","journal-title":"Diabetologia"},{"issue":"1","key":"5637_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/dmrr.1054","volume":"26","author":"B Feng","year":"2010","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S (2010) miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 26(1):40\u201349. https:\/\/doi.org\/10.1002\/dmrr.1054","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"5637_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00395-008-0715-2","volume":"103","author":"S Van Linthout","year":"2008","unstructured":"Van Linthout S, Seeland U, Riad A et al (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103(4):319\u2013327. https:\/\/doi.org\/10.1007\/s00395-008-0715-2","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"5637_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","volume":"47","author":"J Asbun","year":"2006","unstructured":"Asbun J, Villarreal Francisco J (2006) The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy. J Am Coll Cardiol 47(4):693\u2013700. https:\/\/doi.org\/10.1016\/j.jacc.2005.09.050","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"5637_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","volume":"21","author":"D Aronson","year":"2003","unstructured":"Aronson D (2003)Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21(1):3\u201312. https:\/\/doi.org\/10.1097\/00004872-200301000-00002","journal-title":"J Hypertens"},{"issue":"7","key":"5637_CR53","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.2337\/diacare.22.7.1186","volume":"22","author":"TJ Berg","year":"1999","unstructured":"Berg TJ, Snorgaard O, Faber J et al (1999) Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22(7):1186\u20131190. https:\/\/doi.org\/10.2337\/diacare.22.7.1186","journal-title":"Diabetes Care"},{"issue":"5","key":"5637_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1139\/y83-068","volume":"61","author":"GD Lopaschuk","year":"1983","unstructured":"Lopaschuk GD, Katz S, McNeill JH (1983) The effect of alloxan- and streptozotocin-induced diabetes on calcium transport in rat cardiac sarcoplasmic reticulum. The possible involvement of long chain acylcarnitines. Can J Physiol Pharmacol 61(5):439\u2013448. https:\/\/doi.org\/10.1139\/y83-068","journal-title":"Can J Physiol Pharmacol"},{"issue":"12","key":"5637_CR55","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.2337\/diabetes.53.12.3201","volume":"53","author":"DD Belke","year":"2004","unstructured":"Belke DD, Swanson EA, Dillmann WH (2004) Decreased sarcoplasmic reticulum activity and contractility in diabetic db\/db mouse heart. Diabetes 53(12):3201\u20133208. https:\/\/doi.org\/10.2337\/diabetes.53.12.3201","journal-title":"Diabetes"},{"issue":"4","key":"5637_CR56","doi-asserted-by":"publisher","first-page":"H1398","DOI":"10.1152\/ajpheart.00313.2002","volume":"283","author":"KM Choi","year":"2002","unstructured":"Choi KM, Zhong Y, Hoit BD et al (2002) Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283(4):H1398\u2013H1408. https:\/\/doi.org\/10.1152\/ajpheart.00313.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"5637_CR57","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2337\/diabetes.51.4.1166","volume":"51","author":"SU Trost","year":"2002","unstructured":"Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH (2002) Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51(4):1166\u20131171. https:\/\/doi.org\/10.2337\/diabetes.51.4.1166","journal-title":"Diabetes"},{"issue":"5","key":"5637_CR58","doi-asserted-by":"publisher","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","volume":"293","author":"VA Lacombe","year":"2007","unstructured":"Lacombe VA, Viatchenko-Karpinski S, Terentyev D et al (2007) Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol 293(5):R1787\u2013R1797. https:\/\/doi.org\/10.1152\/ajpregu.00059.2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"5637_CR59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2337\/diab.33.2.196","volume":"33","author":"RG Gonzalez","year":"1984","unstructured":"Gonzalez RG, Barnett P, Aguayo J, Cheng HM, Chylack LT Jr (1984) Direct measurement of polyol pathway activity in the ocular lens. Diabetes 33(2):196\u2013199. https:\/\/doi.org\/10.2337\/diab.33.2.196","journal-title":"Diabetes"},{"issue":"5","key":"5637_CR60","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","volume":"259","author":"CR Torres","year":"1984","unstructured":"Torres CR, Hart GW (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259(5):3308\u20133317","journal-title":"J Biol Chem"},{"key":"5637_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.phrs.2016.12.016","volume":"116","author":"CX Qin","year":"2017","unstructured":"Qin CX, Sleaby R, Davidoff AJ et al (2017) Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications. Pharmacol Res 116:45\u201356. https:\/\/doi.org\/10.1016\/j.phrs.2016.12.016","journal-title":"Pharmacol Res"},{"issue":"6","key":"5637_CR62","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.3892\/ijmm.2018.3866","volume":"42","author":"L Huang","year":"2018","unstructured":"Huang L, Yuan P, Yu P et al (2018)O-GlcNAc-modified SNAP29 inhibits autophagy-mediated degradation via the disturbed SNAP29-STX17-VAMP8 complex and exacerbates myocardial injury in type I diabetic rats. Int J Mol Med 42(6):3278\u20133290. https:\/\/doi.org\/10.3892\/ijmm.2018.3866","journal-title":"Int J Mol Med"},{"issue":"5","key":"5637_CR63","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.healun.2010.11.006","volume":"30","author":"J Nozynski","year":"2011","unstructured":"Nozynski J, Zakliczynski M, Konecka-Mrowka D et al (2011) Advanced glycation end-products in myocardium-supported vessels: effects of heart failure and diabetes mellitus. J Heart Lung Transplant 30(5):558\u2013564. https:\/\/doi.org\/10.1016\/j.healun.2010.11.006","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"5637_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","volume":"67","author":"N Ahmed","year":"2005","unstructured":"Ahmed N (2005) Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res Clin Pract 67(1):3\u201321. https:\/\/doi.org\/10.1016\/j.diabres.2004.09.004","journal-title":"Diabetes Res Clin Pract"},{"key":"5637_CR65","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-015-0288-y","volume":"14","author":"Z Liu","year":"2015","unstructured":"Liu Z, Zhao N, Zhu H et al (2015) Circulating interleukin-1beta promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2. Cardiovasc Diabetol 14:125. https:\/\/doi.org\/10.1186\/s12933-015-0288-y","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"5637_CR66","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","volume":"269","author":"SD Yan","year":"1994","unstructured":"Yan SD, Schmidt AM, Anderson GM et al (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins. J Biol Chem 269(13):9889\u20139897","journal-title":"J Biol Chem"},{"issue":"1","key":"5637_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10741-013-9377-8","volume":"19","author":"M Isfort","year":"2014","unstructured":"Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE (2014) Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev 19(1):35\u201348. https:\/\/doi.org\/10.1007\/s10741-013-9377-8","journal-title":"Heart Fail Rev"},{"issue":"7","key":"5637_CR68","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2337\/diabetes.47.7.1086","volume":"47","author":"E Roche","year":"1998","unstructured":"Roche E, Farfari S, Witters LA et al (1998)Long-term exposure of beta-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes 47(7):1086\u20131094. https:\/\/doi.org\/10.2337\/diabetes.47.7.1086","journal-title":"Diabetes"},{"issue":"1","key":"5637_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0005-2728(93)90004-y","volume":"1183","author":"L Wojtczak","year":"1993","unstructured":"Wojtczak L, Schonfeld P (1993) Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1183(1):41\u201357. https:\/\/doi.org\/10.1016\/0005-2728(93)90004-y","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"5637_CR70","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","volume":"97","author":"YT Zhou","year":"2000","unstructured":"Zhou YT, Grayburn P, Karim A et al (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97(4):1784\u20131789. https:\/\/doi.org\/10.1073\/pnas.97.4.1784","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"5637_CR71","doi-asserted-by":"publisher","first-page":"14890","DOI":"10.1074\/jbc.M010286200","volume":"276","author":"LL Listenberger","year":"2001","unstructured":"Listenberger LL, Ory DS, Schaffer JE (2001)Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276(18):14890\u201314895. https:\/\/doi.org\/10.1074\/jbc.M010286200","journal-title":"J Biol Chem"},{"issue":"7","key":"5637_CR72","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0022-2275(20)37421-6","volume":"38","author":"JE de Vries","year":"1997","unstructured":"de Vries JE, Vork MM, Roemen TH et al (1997) Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 38(7):1384\u20131394","journal-title":"J Lipid Res"},{"issue":"9","key":"5637_CR73","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/sj.embor.7400779","volume":"7","author":"E Szegezdi","year":"2006","unstructured":"Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7(9):880\u2013885. https:\/\/doi.org\/10.1038\/sj.embor.7400779","journal-title":"EMBO Rep"},{"issue":"12","key":"5637_CR74","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014046","volume":"9","author":"N Masaki","year":"2020","unstructured":"Masaki N, Feng B, Breton-Romero R et al (2020)O-GlcNAcylation Mediates Glucose-Induced Alterations in Endothelial Cell Phenotype in Human Diabetes Mellitus. J Am Heart Assoc 9(12):e014046. https:\/\/doi.org\/10.1161\/JAHA.119.014046","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"5637_CR75","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/01.RES.0000165478.06813.58","volume":"96","author":"Y Hu","year":"2005","unstructured":"Hu Y, Belke D, Suarez J et al (2005)Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96(9):1006\u20131013. https:\/\/doi.org\/10.1161\/01.RES.0000165478.06813.58","journal-title":"Circ Res"},{"issue":"6","key":"5637_CR76","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1006\/jmcc.2000.1139","volume":"32","author":"C Depre","year":"2000","unstructured":"Depre C, Young ME, Ying J et al (2000)Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32(6):985\u2013996","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"5637_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2840-11-15","volume":"11","author":"V Skov","year":"2012","unstructured":"Skov V, Knudsen S, Olesen M, Hansen ML, Rasmussen LM (2012) Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes. Cardiovasc Diabetol 11(1):15. https:\/\/doi.org\/10.1186\/1475-2840-11-15","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"5637_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40618-018-0956-3","volume":"42","author":"S Costantino","year":"2019","unstructured":"Costantino S, Ambrosini S, Paneni F (2019) The epigenetic landscape in the cardiovascular complications of diabetes. J Endocrinol Investig 42(5):505\u2013511. https:\/\/doi.org\/10.1007\/s40618-018-0956-3","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"5637_CR79","doi-asserted-by":"publisher","first-page":"H674","DOI":"10.1152\/ajpheart.00016.2019","volume":"317","author":"ME Pepin","year":"2019","unstructured":"Pepin ME, Drakos S, Ha C-M et al (2019) DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. Am J Phys Heart Circ Phys 317(4):H674\u2013H684. https:\/\/doi.org\/10.1152\/ajpheart.00016.2019","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"4","key":"5637_CR80","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/ehf2.12789","volume":"7","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang Y, Qiu C et al (2020) Diabetes mellitus exacerbates post-myocardial infarction heart failure by reducing sarcolipin promoter methylation. ESC Heart Fail 7(4):1935\u20131948","journal-title":"ESC Heart Fail"},{"issue":"15","key":"5637_CR81","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1042\/CS20170064","volume":"131","author":"Z Xu","year":"2017","unstructured":"Xu Z, Tong Q, Zhang Z et al (2017) Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway. Clin Sci 131(15):1841\u20131857","journal-title":"Clin Sci"},{"issue":"10","key":"5637_CR82","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1161\/CIRCRESAHA.120.317132","volume":"127","author":"S Hussain","year":"2020","unstructured":"Hussain S, Khan AW, Akhmedov A et al (2020) Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD. Circ Res 127(10):1261\u20131273","journal-title":"Circ Res"},{"issue":"1","key":"5637_CR83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","volume":"14","author":"Y Chen","year":"2015","unstructured":"Chen Y, Du J, Zhao YT et al (2015) Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol 14(1):99. https:\/\/doi.org\/10.1186\/s12933-015-0262-8","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"5637_CR84","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","volume":"37","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, L\u00fcscher TF, Cosentino F (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37(6):572\u2013576","journal-title":"Eur Heart J"},{"issue":"1","key":"5637_CR85","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/bj20121038","volume":"449","author":"SS Vadvalkar","year":"2013","unstructured":"Vadvalkar SS, Baily CN, Matsuzaki S, West M, Tesiram YA, Humphries KM (2013) Metabolic inflexibility and protein lysine acetylation in heart mitochondria of a chronic model of type 1 diabetes. The Biochemical journal 449(1):253\u2013261. https:\/\/doi.org\/10.1042\/bj20121038","journal-title":"The Biochemical journal"},{"issue":"4","key":"5637_CR86","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/cvr\/cvv183","volume":"107","author":"EJ Vazquez","year":"2015","unstructured":"Vazquez EJ, Berthiaume JM, Kamath V et al (2015) Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart. Cardiovasc Res 107(4):453\u2013465","journal-title":"Cardiovasc Res"},{"issue":"4","key":"5637_CR87","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/cvr\/cvu156","volume":"103","author":"OA Alrob","year":"2014","unstructured":"Alrob OA, Sankaralingam S, Ma C et al (2014)Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovasc Res 103(4):485\u2013497. https:\/\/doi.org\/10.1093\/cvr\/cvu156","journal-title":"Cardiovasc Res"},{"key":"5637_CR88","doi-asserted-by":"publisher","unstructured":"Horton JL, Martin OJ, Lai L et al (2016) Mitochondrial protein hyperacetylation in the failing heart. JCI Insight 1(2). https:\/\/doi.org\/10.1172\/jci.insight.84897","DOI":"10.1172\/jci.insight.84897"},{"issue":"8","key":"5637_CR89","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.120.317293","volume":"127","author":"MT Davidson","year":"2020","unstructured":"Davidson MT, Grimsrud PA, Lai L et al (2020) Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure. Circ Res 127(8):1094\u20131108","journal-title":"Circ Res"},{"issue":"4","key":"5637_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 375(4):311\u2013322. https:\/\/doi.org\/10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"issue":"22","key":"5637_CR91","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 373(22):2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"issue":"6","key":"5637_CR92","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","volume":"5","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Verma S (2020) Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. JACC Basic Transl Sci 5(6):632\u2013644. https:\/\/doi.org\/10.1016\/j.jacbts.2020.02.004","journal-title":"JACC Basic Transl Sci"},{"key":"5637_CR93","doi-asserted-by":"publisher","first-page":"603247","DOI":"10.3389\/fphys.2020.603247","volume":"11","author":"K Gopal","year":"2020","unstructured":"Gopal K, Chahade JJ, Kim R, Ussher JR (2020) The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy. Front Physiol 11:603247. https:\/\/doi.org\/10.3389\/fphys.2020.603247","journal-title":"Front Physiol"},{"key":"5637_CR94","doi-asserted-by":"publisher","unstructured":"Berndt J, Ooi SL, Pak SC (2021) What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Receptor Agonists?-A Mini Review. Molecules 26(16). https:\/\/doi.org\/10.3390\/molecules26164822","DOI":"10.3390\/molecules26164822"},{"issue":"10","key":"5637_CR95","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED (2021) Cardiac Energy Metabolism in Heart Failure. Circ Res 128(10):1487\u20131513. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241","journal-title":"Circ Res"},{"issue":"1","key":"5637_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0002-9149(88)91306-9","volume":"61","author":"TJ Wargovich","year":"1988","unstructured":"Wargovich TJ, MacDonald RG, Hill JA, Feldman RL, Stacpoole PW, Pepine CJ (1988) Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 61(1):65\u201370. https:\/\/doi.org\/10.1016\/0002-9149(88)91306-9","journal-title":"Am J Cardiol"},{"issue":"7","key":"5637_CR97","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0735-1097(94)90665-3","volume":"23","author":"RM Bersin","year":"1994","unstructured":"Bersin RM, Wolfe C, Kwasman M et al (1994) Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol 23(7):1617\u20131624. https:\/\/doi.org\/10.1016\/0735-1097(94)90665-3","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"5637_CR98","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.2337\/db14-1560","volume":"64","author":"LM Le Page","year":"2015","unstructured":"Le Page LM, Rider OJ, Lewis AJ et al (2015) Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study. Diabetes 64(8):2735\u20132743. https:\/\/doi.org\/10.2337\/db14-1560","journal-title":"Diabetes"},{"issue":"3","key":"5637_CR99","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/jci60329","volume":"122","author":"PK Battiprolu","year":"2012","unstructured":"Battiprolu PK, Hojayev B, Jiang N et al (2012) Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest 122(3):1109\u20131118. https:\/\/doi.org\/10.1172\/jci60329","journal-title":"J Clin Invest"},{"key":"5637_CR100","doi-asserted-by":"publisher","unstructured":"Seetharaman R, Pawar S, Advani M (2021) Hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of Diabetes Mellitus. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.15100","DOI":"10.1111\/bcp.15100"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05637-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05637-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05637-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T20:03:44Z","timestamp":1673035424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05637-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5637"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05637-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}